Medical Services International Inc.
Medical Services International Inc. MSITF Peers
See (MSITF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MSITF | $0.00 | N/A | 4.8K | -0.00 | -$0.00 | N/A |
| FSNUY | $12.11 | -1.30% | 109.1B | 22.85 | $0.53 | +2.01% |
| RVLWF | $0.04 | +97.97% | 38.6B | -0.30 | -$0.13 | N/A |
| FSNUF | $37.73 | N/A | 21.3B | 17.80 | $2.12 | +2.47% |
| FMCQF | $57.26 | +20.55% | 16.8B | 23.96 | $2.39 | +2.53% |
| BDUUY | $32.33 | N/A | 12.8B | 28.36 | $1.14 | +2.79% |
| BDULF | $0.71 | -16.58% | 11.3B | 23.67 | $0.03 | +3.13% |
| JDHIY | $3.25 | +100.00% | 10.4B | 18.06 | $0.18 | N/A |
| JDHIF | $3.23 | N/A | 10.3B | 26.92 | $0.12 | N/A |
| IHHHF | $1.10 | -7.56% | 9.7B | 15.71 | $0.07 | +1.25% |
Stock Comparison
MSITF vs FSNUY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, FSNUY has a market cap of 109.1B. Regarding current trading prices, MSITF is priced at $0.00, while FSNUY trades at $12.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas FSNUY's P/E ratio is 22.85. In terms of profitability, MSITF's ROE is N/A, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, MSITF is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs RVLWF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RVLWF has a market cap of 38.6B. Regarding current trading prices, MSITF is priced at $0.00, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, MSITF's ROE is N/A, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, MSITF and RVLWF have similar daily volatility (0.00).
MSITF vs FSNUF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, FSNUF has a market cap of 21.3B. Regarding current trading prices, MSITF is priced at $0.00, while FSNUF trades at $37.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas FSNUF's P/E ratio is 17.80. In terms of profitability, MSITF's ROE is N/A, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, MSITF is less volatile compared to FSNUF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs FMCQF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, FMCQF has a market cap of 16.8B. Regarding current trading prices, MSITF is priced at $0.00, while FMCQF trades at $57.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas FMCQF's P/E ratio is 23.96. In terms of profitability, MSITF's ROE is N/A, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, MSITF is less volatile compared to FMCQF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs BDUUY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, MSITF is priced at $0.00, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, MSITF's ROE is N/A, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, MSITF is less volatile compared to BDUUY. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs BDULF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BDULF has a market cap of 11.3B. Regarding current trading prices, MSITF is priced at $0.00, while BDULF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BDULF's P/E ratio is 23.67. In terms of profitability, MSITF's ROE is N/A, compared to BDULF's ROE of +0.16%. Regarding short-term risk, MSITF is less volatile compared to BDULF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs JDHIY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, JDHIY has a market cap of 10.4B. Regarding current trading prices, MSITF is priced at $0.00, while JDHIY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas JDHIY's P/E ratio is 18.06. In terms of profitability, MSITF's ROE is N/A, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, MSITF and JDHIY have similar daily volatility (0.00).
MSITF vs JDHIF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, JDHIF has a market cap of 10.3B. Regarding current trading prices, MSITF is priced at $0.00, while JDHIF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas JDHIF's P/E ratio is 26.92. In terms of profitability, MSITF's ROE is N/A, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, MSITF is less volatile compared to JDHIF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs IHHHF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, IHHHF has a market cap of 9.7B. Regarding current trading prices, MSITF is priced at $0.00, while IHHHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, MSITF's ROE is N/A, compared to IHHHF's ROE of +0.09%. Regarding short-term risk, MSITF is less volatile compared to IHHHF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs BDUUF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BDUUF has a market cap of 9.5B. Regarding current trading prices, MSITF is priced at $0.00, while BDUUF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BDUUF's P/E ratio is 20.00. In terms of profitability, MSITF's ROE is N/A, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, MSITF is less volatile compared to BDUUF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs RMYHY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RMYHY has a market cap of 5.4B. Regarding current trading prices, MSITF is priced at $0.00, while RMYHY trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RMYHY's P/E ratio is 565.00. In terms of profitability, MSITF's ROE is N/A, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, MSITF is less volatile compared to RMYHY. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs RMSYF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RMSYF has a market cap of 5.1B. Regarding current trading prices, MSITF is priced at $0.00, while RMSYF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RMSYF's P/E ratio is 440.00. In terms of profitability, MSITF's ROE is N/A, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, MSITF is less volatile compared to RMSYF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs BUGDF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BUGDF has a market cap of 5B. Regarding current trading prices, MSITF is priced at $0.00, while BUGDF trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BUGDF's P/E ratio is 24.27. In terms of profitability, MSITF's ROE is N/A, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, MSITF is less volatile compared to BUGDF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs ANHGY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, MSITF is priced at $0.00, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, MSITF's ROE is N/A, compared to ANHGY's ROE of N/A. Regarding short-term risk, MSITF and ANHGY have similar daily volatility (0.00).
MSITF vs BUHPF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BUHPF has a market cap of 3.4B. Regarding current trading prices, MSITF is priced at $0.00, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BUHPF's P/E ratio is 17.96. In terms of profitability, MSITF's ROE is N/A, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, MSITF is less volatile compared to BUHPF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs MCVEF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MCVEF has a market cap of 3B. Regarding current trading prices, MSITF is priced at $0.00, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MCVEF's P/E ratio is 86.22. In terms of profitability, MSITF's ROE is N/A, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, MSITF is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs ORPEF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, MSITF is priced at $0.00, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, MSITF's ROE is N/A, compared to ORPEF's ROE of +0.91%. Regarding short-term risk, MSITF is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs TTALF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, TTALF has a market cap of 1.6B. Regarding current trading prices, MSITF is priced at $0.00, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas TTALF's P/E ratio is 19.33. In terms of profitability, MSITF's ROE is N/A, compared to TTALF's ROE of +0.15%. Regarding short-term risk, MSITF and TTALF have similar daily volatility (0.00).
MSITF vs MCVEY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MCVEY has a market cap of 1.6B. Regarding current trading prices, MSITF is priced at $0.00, while MCVEY trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MCVEY's P/E ratio is 52.54. In terms of profitability, MSITF's ROE is N/A, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, MSITF is less volatile compared to MCVEY. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs RYHTY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RYHTY has a market cap of 1.5B. Regarding current trading prices, MSITF is priced at $0.00, while RYHTY trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RYHTY's P/E ratio is -20.42. In terms of profitability, MSITF's ROE is N/A, compared to RYHTY's ROE of +0.00%. Regarding short-term risk, MSITF and RYHTY have similar daily volatility (0.00).
MSITF vs RHCGF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RHCGF has a market cap of 1.4B. Regarding current trading prices, MSITF is priced at $0.00, while RHCGF trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RHCGF's P/E ratio is -20.14. In terms of profitability, MSITF's ROE is N/A, compared to RHCGF's ROE of -0.02%. Regarding short-term risk, MSITF is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs LWSCF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, LWSCF has a market cap of 1.2B. Regarding current trading prices, MSITF is priced at $0.00, while LWSCF trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas LWSCF's P/E ratio is 43.63. In terms of profitability, MSITF's ROE is N/A, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, MSITF is less volatile compared to LWSCF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs LTGHF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, LTGHF has a market cap of 1.2B. Regarding current trading prices, MSITF is priced at $0.00, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas LTGHF's P/E ratio is 11.70. In terms of profitability, MSITF's ROE is N/A, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, MSITF is less volatile compared to LTGHF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs RAFLF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RAFLF has a market cap of 1.1B. Regarding current trading prices, MSITF is priced at $0.00, while RAFLF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RAFLF's P/E ratio is 20.00. In terms of profitability, MSITF's ROE is N/A, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, MSITF is less volatile compared to RAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs LTGHY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, LTGHY has a market cap of 1.1B. Regarding current trading prices, MSITF is priced at $0.00, while LTGHY trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas LTGHY's P/E ratio is -21.50. In terms of profitability, MSITF's ROE is N/A, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, MSITF is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs RKAGY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RKAGY has a market cap of 1.1B. Regarding current trading prices, MSITF is priced at $0.00, while RKAGY trades at $7.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RKAGY's P/E ratio is 23.09. In terms of profitability, MSITF's ROE is N/A, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, MSITF is less volatile compared to RKAGY. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs RHKJF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, MSITF is priced at $0.00, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, MSITF's ROE is N/A, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, MSITF is less volatile compared to RHKJF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs NWKHY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NWKHY has a market cap of 950.7M. Regarding current trading prices, MSITF is priced at $0.00, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NWKHY's P/E ratio is 13.22. In terms of profitability, MSITF's ROE is N/A, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, MSITF and NWKHY have similar daily volatility (0.00).
MSITF vs EXETF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, EXETF has a market cap of 878.1M. Regarding current trading prices, MSITF is priced at $0.00, while EXETF trades at $10.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas EXETF's P/E ratio is 16.44. In terms of profitability, MSITF's ROE is N/A, compared to EXETF's ROE of +0.66%. Regarding short-term risk, MSITF is less volatile compared to EXETF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs JXFGF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, JXFGF has a market cap of 755.6M. Regarding current trading prices, MSITF is priced at $0.00, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, MSITF's ROE is N/A, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, MSITF is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs WHTCF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, WHTCF has a market cap of 754.1M. Regarding current trading prices, MSITF is priced at $0.00, while WHTCF trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas WHTCF's P/E ratio is -37.25. In terms of profitability, MSITF's ROE is N/A, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, MSITF is less volatile compared to WHTCF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs KDGTF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, MSITF is priced at $0.00, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, MSITF's ROE is N/A, compared to KDGTF's ROE of N/A. Regarding short-term risk, MSITF and KDGTF have similar daily volatility (0.00).
MSITF vs WFHG Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, WFHG has a market cap of 471.2M. Regarding current trading prices, MSITF is priced at $0.00, while WFHG trades at $7.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas WFHG's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to WFHG's ROE of +0.22%. Regarding short-term risk, MSITF is less volatile compared to WFHG. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs ORRRY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, MSITF is priced at $0.00, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, MSITF's ROE is N/A, compared to ORRRY's ROE of +73.42%. Regarding short-term risk, MSITF and ORRRY have similar daily volatility (0.00).
MSITF vs BTMDW Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, MSITF is priced at $0.00, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, MSITF's ROE is N/A, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, MSITF is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs EVGRF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, EVGRF has a market cap of 235.2M. Regarding current trading prices, MSITF is priced at $0.00, while EVGRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas EVGRF's P/E ratio is -0.05. In terms of profitability, MSITF's ROE is N/A, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, MSITF is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs MKLNF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MKLNF has a market cap of 224.3M. Regarding current trading prices, MSITF is priced at $0.00, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, MSITF's ROE is N/A, compared to MKLNF's ROE of +0.15%. Regarding short-term risk, MSITF and MKLNF have similar daily volatility (0.00).
MSITF vs MFCSF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MFCSF has a market cap of 220.5M. Regarding current trading prices, MSITF is priced at $0.00, while MFCSF trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MFCSF's P/E ratio is 7.45. In terms of profitability, MSITF's ROE is N/A, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, MSITF is less volatile compared to MFCSF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs CHHHF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, CHHHF has a market cap of 123.5M. Regarding current trading prices, MSITF is priced at $0.00, while CHHHF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas CHHHF's P/E ratio is -49.00. In terms of profitability, MSITF's ROE is N/A, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, MSITF and CHHHF have similar daily volatility (0.00).
MSITF vs VTIAF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, VTIAF has a market cap of 104.4M. Regarding current trading prices, MSITF is priced at $0.00, while VTIAF trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas VTIAF's P/E ratio is -3.59. In terms of profitability, MSITF's ROE is N/A, compared to VTIAF's ROE of +0.11%. Regarding short-term risk, MSITF is less volatile compared to VTIAF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs MCIOF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, MSITF is priced at $0.00, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, MSITF's ROE is N/A, compared to MCIOF's ROE of N/A. Regarding short-term risk, MSITF and MCIOF have similar daily volatility (0.00).
MSITF vs ASSF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, MSITF is priced at $0.00, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas ASSF's P/E ratio is -33.33. In terms of profitability, MSITF's ROE is N/A, compared to ASSF's ROE of -6.63%. Regarding short-term risk, MSITF and ASSF have similar daily volatility (0.00).
MSITF vs KONEF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, KONEF has a market cap of 44.3M. Regarding current trading prices, MSITF is priced at $0.00, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas KONEF's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to KONEF's ROE of -6.56%. Regarding short-term risk, MSITF is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs HQDA Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, MSITF is priced at $0.00, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas HQDA's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to HQDA's ROE of +0.00%. Regarding short-term risk, MSITF and HQDA have similar daily volatility (0.00).
MSITF vs USNU Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, USNU has a market cap of 18.6M. Regarding current trading prices, MSITF is priced at $0.00, while USNU trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas USNU's P/E ratio is -7.25. In terms of profitability, MSITF's ROE is N/A, compared to USNU's ROE of -0.62%. Regarding short-term risk, MSITF is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs NVLPF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NVLPF has a market cap of 17M. Regarding current trading prices, MSITF is priced at $0.00, while NVLPF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NVLPF's P/E ratio is 19.50. In terms of profitability, MSITF's ROE is N/A, compared to NVLPF's ROE of +0.08%. Regarding short-term risk, MSITF is less volatile compared to NVLPF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs FPCG Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, FPCG has a market cap of 10.3M. Regarding current trading prices, MSITF is priced at $0.00, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas FPCG's P/E ratio is 0.09. In terms of profitability, MSITF's ROE is N/A, compared to FPCG's ROE of +0.00%. Regarding short-term risk, MSITF and FPCG have similar daily volatility (0.00).
MSITF vs XCRT Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, XCRT has a market cap of 9M. Regarding current trading prices, MSITF is priced at $0.00, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas XCRT's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to XCRT's ROE of +2.48%. Regarding short-term risk, MSITF is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs NUMIF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NUMIF has a market cap of 6.7M. Regarding current trading prices, MSITF is priced at $0.00, while NUMIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NUMIF's P/E ratio is -0.34. In terms of profitability, MSITF's ROE is N/A, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, MSITF is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs HLYK Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, HLYK has a market cap of 5.3M. Regarding current trading prices, MSITF is priced at $0.00, while HLYK trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas HLYK's P/E ratio is -0.94. In terms of profitability, MSITF's ROE is N/A, compared to HLYK's ROE of +2.41%. Regarding short-term risk, MSITF is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs BICX Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BICX has a market cap of 5.1M. Regarding current trading prices, MSITF is priced at $0.00, while BICX trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BICX's P/E ratio is -0.73. In terms of profitability, MSITF's ROE is N/A, compared to BICX's ROE of +0.40%. Regarding short-term risk, MSITF is less volatile compared to BICX. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs GBCS Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, GBCS has a market cap of 4.9M. Regarding current trading prices, MSITF is priced at $0.00, while GBCS trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas GBCS's P/E ratio is -2.35. In terms of profitability, MSITF's ROE is N/A, compared to GBCS's ROE of +0.56%. Regarding short-term risk, MSITF and GBCS have similar daily volatility (0.00).
MSITF vs RHEP Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, RHEP has a market cap of 4.5M. Regarding current trading prices, MSITF is priced at $0.00, while RHEP trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas RHEP's P/E ratio is -0.98. In terms of profitability, MSITF's ROE is N/A, compared to RHEP's ROE of +1.29%. Regarding short-term risk, MSITF and RHEP have similar daily volatility (0.00).
MSITF vs VLXC Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, VLXC has a market cap of 4.3M. Regarding current trading prices, MSITF is priced at $0.00, while VLXC trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas VLXC's P/E ratio is -6.00. In terms of profitability, MSITF's ROE is N/A, compared to VLXC's ROE of +0.68%. Regarding short-term risk, MSITF and VLXC have similar daily volatility (0.00).
MSITF vs GRST Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, GRST has a market cap of 3.1M. Regarding current trading prices, MSITF is priced at $0.00, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas GRST's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to GRST's ROE of +0.30%. Regarding short-term risk, MSITF is less volatile compared to GRST. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs EPWCF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, MSITF is priced at $0.00, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas EPWCF's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, MSITF is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs JRSS Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, JRSS has a market cap of 1.9M. Regarding current trading prices, MSITF is priced at $0.00, while JRSS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas JRSS's P/E ratio is -0.37. In terms of profitability, MSITF's ROE is N/A, compared to JRSS's ROE of +2.63%. Regarding short-term risk, MSITF and JRSS have similar daily volatility (0.00).
MSITF vs TOKIF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, TOKIF has a market cap of 1.8M. Regarding current trading prices, MSITF is priced at $0.00, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, MSITF's ROE is N/A, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, MSITF is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs SMAS Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, MSITF is priced at $0.00, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas SMAS's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to SMAS's ROE of N/A. Regarding short-term risk, MSITF is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs MDGP Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, MSITF is priced at $0.00, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MDGP's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to MDGP's ROE of -2.19%. Regarding short-term risk, MSITF and MDGP have similar daily volatility (0.00).
MSITF vs NOVC Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, MSITF is priced at $0.00, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NOVC's P/E ratio is -0.20. In terms of profitability, MSITF's ROE is N/A, compared to NOVC's ROE of +0.12%. Regarding short-term risk, MSITF and NOVC have similar daily volatility (0.00).
MSITF vs PHMB Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, MSITF is priced at $0.00, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas PHMB's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to PHMB's ROE of N/A. Regarding short-term risk, MSITF is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs GNOW Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, MSITF is priced at $0.00, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas GNOW's P/E ratio is -0.01. In terms of profitability, MSITF's ROE is N/A, compared to GNOW's ROE of +0.00%. Regarding short-term risk, MSITF and GNOW have similar daily volatility (0.00).
MSITF vs DPAT Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, DPAT has a market cap of 397.4K. Regarding current trading prices, MSITF is priced at $0.00, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas DPAT's P/E ratio is -1.65. In terms of profitability, MSITF's ROE is N/A, compared to DPAT's ROE of +0.45%. Regarding short-term risk, MSITF and DPAT have similar daily volatility (0.00).
MSITF vs KJFI Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, KJFI has a market cap of 374.6K. Regarding current trading prices, MSITF is priced at $0.00, while KJFI trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas KJFI's P/E ratio is -0.06. In terms of profitability, MSITF's ROE is N/A, compared to KJFI's ROE of +0.00%. Regarding short-term risk, MSITF and KJFI have similar daily volatility (0.00).
MSITF vs NXGT Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NXGT has a market cap of 369.9K. Regarding current trading prices, MSITF is priced at $0.00, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NXGT's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to NXGT's ROE of +0.09%. Regarding short-term risk, MSITF and NXGT have similar daily volatility (0.00).
MSITF vs SETO Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, SETO has a market cap of 343K. Regarding current trading prices, MSITF is priced at $0.00, while SETO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas SETO's P/E ratio is -2.75. In terms of profitability, MSITF's ROE is N/A, compared to SETO's ROE of +0.00%. Regarding short-term risk, MSITF is less volatile compared to SETO. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs ARPC Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, MSITF is priced at $0.00, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas ARPC's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to ARPC's ROE of -0.56%. Regarding short-term risk, MSITF is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs FCHS Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, FCHS has a market cap of 197.8K. Regarding current trading prices, MSITF is priced at $0.00, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas FCHS's P/E ratio is -0.05. In terms of profitability, MSITF's ROE is N/A, compared to FCHS's ROE of +0.12%. Regarding short-term risk, MSITF is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs JNHMF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, JNHMF has a market cap of 165.4K. Regarding current trading prices, MSITF is priced at $0.00, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas JNHMF's P/E ratio is -0.07. In terms of profitability, MSITF's ROE is N/A, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, MSITF and JNHMF have similar daily volatility (0.00).
MSITF vs HSMD Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, HSMD has a market cap of 153.4K. Regarding current trading prices, MSITF is priced at $0.00, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas HSMD's P/E ratio is -0.05. In terms of profitability, MSITF's ROE is N/A, compared to HSMD's ROE of -0.04%. Regarding short-term risk, MSITF and HSMD have similar daily volatility (0.00).
MSITF vs BNYN Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BNYN has a market cap of 150.5K. Regarding current trading prices, MSITF is priced at $0.00, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BNYN's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to BNYN's ROE of -14.10%. Regarding short-term risk, MSITF is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs CLRD Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, CLRD has a market cap of 140.7K. Regarding current trading prices, MSITF is priced at $0.00, while CLRD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas CLRD's P/E ratio is -0.01. In terms of profitability, MSITF's ROE is N/A, compared to CLRD's ROE of +0.38%. Regarding short-term risk, MSITF is less volatile compared to CLRD. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs COLRF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, COLRF has a market cap of 129.7K. Regarding current trading prices, MSITF is priced at $0.00, while COLRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas COLRF's P/E ratio is -0.01. In terms of profitability, MSITF's ROE is N/A, compared to COLRF's ROE of +0.02%. Regarding short-term risk, MSITF and COLRF have similar daily volatility (0.00).
MSITF vs TPIA Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, MSITF is priced at $0.00, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas TPIA's P/E ratio is -0.15. In terms of profitability, MSITF's ROE is N/A, compared to TPIA's ROE of +0.61%. Regarding short-term risk, MSITF is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs AMBD Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, MSITF is priced at $0.00, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas AMBD's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to AMBD's ROE of +1.11%. Regarding short-term risk, MSITF is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs NMHLY Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, MSITF is priced at $0.00, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, MSITF's ROE is N/A, compared to NMHLY's ROE of N/A. Regarding short-term risk, MSITF and NMHLY have similar daily volatility (0.00).
MSITF vs GENN Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, GENN has a market cap of 32.7K. Regarding current trading prices, MSITF is priced at $0.00, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas GENN's P/E ratio is -0.02. In terms of profitability, MSITF's ROE is N/A, compared to GENN's ROE of +0.00%. Regarding short-term risk, MSITF and GENN have similar daily volatility (0.00).
MSITF vs DRWN Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, MSITF is priced at $0.00, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas DRWN's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to DRWN's ROE of -0.01%. Regarding short-term risk, MSITF is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs SCAL Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, MSITF is priced at $0.00, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas SCAL's P/E ratio is 0.04. In terms of profitability, MSITF's ROE is N/A, compared to SCAL's ROE of +0.07%. Regarding short-term risk, MSITF and SCAL have similar daily volatility (0.00).
MSITF vs CHCR Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, MSITF is priced at $0.00, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas CHCR's P/E ratio is -0.00. In terms of profitability, MSITF's ROE is N/A, compared to CHCR's ROE of N/A. Regarding short-term risk, MSITF and CHCR have similar daily volatility (0.00).
MSITF vs ACGI Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, MSITF is priced at $0.00, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas ACGI's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to ACGI's ROE of +1.11%. Regarding short-term risk, MSITF is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs CEVE Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, CEVE has a market cap of 7.7K. Regarding current trading prices, MSITF is priced at $0.00, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas CEVE's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to CEVE's ROE of +2.26%. Regarding short-term risk, MSITF and CEVE have similar daily volatility (0.00).
MSITF vs NAFS Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NAFS has a market cap of 7K. Regarding current trading prices, MSITF is priced at $0.00, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NAFS's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to NAFS's ROE of +1.02%. Regarding short-term risk, MSITF is less volatile compared to NAFS. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs PRMD Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, PRMD has a market cap of 5.6K. Regarding current trading prices, MSITF is priced at $0.00, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas PRMD's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to PRMD's ROE of +0.73%. Regarding short-term risk, MSITF is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs MSGP Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, MSITF is priced at $0.00, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MSGP's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to MSGP's ROE of +0.27%. Regarding short-term risk, MSITF and MSGP have similar daily volatility (0.00).
MSITF vs ERUC Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, MSITF is priced at $0.00, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas ERUC's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to ERUC's ROE of N/A. Regarding short-term risk, MSITF is less volatile compared to ERUC. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs SLHPF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, MSITF is priced at $0.00, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas SLHPF's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, MSITF is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs WEQL Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, MSITF is priced at $0.00, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas WEQL's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to WEQL's ROE of +0.21%. Regarding short-term risk, MSITF and WEQL have similar daily volatility (0.00).
MSITF vs BBAL Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, MSITF is priced at $0.00, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BBAL's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to BBAL's ROE of +0.45%. Regarding short-term risk, MSITF and BBAL have similar daily volatility (0.00).
MSITF vs PAOG Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, PAOG has a market cap of 2.5K. Regarding current trading prices, MSITF is priced at $0.00, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas PAOG's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to PAOG's ROE of +0.08%. Regarding short-term risk, MSITF is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs NMMCF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, MSITF is priced at $0.00, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, MSITF's ROE is N/A, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, MSITF is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs PPRG Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, MSITF is priced at $0.00, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas PPRG's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to PPRG's ROE of -0.58%. Regarding short-term risk, MSITF and PPRG have similar daily volatility (0.00).
MSITF vs OHAQ Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, MSITF is priced at $0.00, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, MSITF's ROE is N/A, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, MSITF and OHAQ have similar daily volatility (0.00).
MSITF vs BNKL Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, MSITF is priced at $0.00, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas BNKL's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to BNKL's ROE of -7.69%. Regarding short-term risk, MSITF and BNKL have similar daily volatility (0.00).
MSITF vs MAHN Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, MAHN has a market cap of 1.2K. Regarding current trading prices, MSITF is priced at $0.00, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas MAHN's P/E ratio is 0.05. In terms of profitability, MSITF's ROE is N/A, compared to MAHN's ROE of N/A. Regarding short-term risk, MSITF is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for MSITF.
MSITF vs SLHGF Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, SLHGF has a market cap of 398. Regarding current trading prices, MSITF is priced at $0.00, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas SLHGF's P/E ratio is -0.00. In terms of profitability, MSITF's ROE is N/A, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, MSITF and SLHGF have similar daily volatility (0.00).
MSITF vs LHRP Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, LHRP has a market cap of 340. Regarding current trading prices, MSITF is priced at $0.00, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas LHRP's P/E ratio is 0.00. In terms of profitability, MSITF's ROE is N/A, compared to LHRP's ROE of N/A. Regarding short-term risk, MSITF and LHRP have similar daily volatility (0.00).
MSITF vs NMSCA Comparison
MSITF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSITF stands at 4.8K. In comparison, NMSCA has a market cap of 275. Regarding current trading prices, MSITF is priced at $0.00, while NMSCA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSITF currently has a P/E ratio of -0.00, whereas NMSCA's P/E ratio is N/A. In terms of profitability, MSITF's ROE is N/A, compared to NMSCA's ROE of +0.02%. Regarding short-term risk, MSITF and NMSCA have similar daily volatility (0.00).